Journal of Oncological Sciences最新文献_第6页

Seasonal Influenza and Pneumococcal Vaccination Rates Among Patients with Cancer in COVID-19 Pandemic: A Cross-Sectional Study COVID-19大流行期间癌症患者的季节性流感和肺炎球菌疫苗接种率:一项横断面研究

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/jos.2021-83087

E. Yekedüz, E. B. Köksoy, S. C. Yazgan, I. Akbıyık, S. Balli, E. Kavak, E. Kalacı, B. Dursun, Pınar Kubilay Tolunay, M. Gürbüz, H. Akbulut, A. Demirkazık, F. Çay Şenler, G. Utkan, Y. Ürün

{"title":"Seasonal Influenza and Pneumococcal Vaccination Rates Among Patients with Cancer in COVID-19 Pandemic: A Cross-Sectional Study","authors":"E. Yekedüz, E. B. Köksoy, S. C. Yazgan, I. Akbıyık, S. Balli, E. Kavak, E. Kalacı, B. Dursun, Pınar Kubilay Tolunay, M. Gürbüz, H. Akbulut, A. Demirkazık, F. Çay Şenler, G. Utkan, Y. Ürün","doi":"10.37047/jos.2021-83087","DOIUrl":"https://doi.org/10.37047/jos.2021-83087","url":null,"abstract":"Objective: Influenza and pneumococcal vaccination rates were not in the expected levels before the coronavirus disease-2019 (COVID-19) pandemic among patients with cancer. However, pandemic conditions may have changed the attitude of patients. In this study, we aimed to assess current influenza and pneumococcal vaccination rates of patients with cancer and changing attitudes toward vaccination in these patients. Material and Methods: This cross-sectional study was conducted in a tertiary cancer center in Turkey. A self-administered questionnaire consisting of 20 items was used. Results: A total of 309 patients completed the questionnaires. Most patients did not get a flu shot and pneumococcal vaccine before the COVID-19 pandemic (74.1% for flu shot and 84.1% for pneumococcal vaccine). Moreover, 144 patients (46.6%) stated that they were considering to get a flu shot, and 133 (43%) were considering to get a pneumococcal vaccine because of the COVID-19 pandemic. Only 35 patients (11.3%) got a flu shot, and 56 (18.1%) got a pneumococcal vaccine during the COVID-19 pan-demic. Conclusion: Vaccination rates for seasonal influenza and pneumococcal infections were low in patients with cancer before the COVID-19 pandemic. Although the number of patients who want to be vaccinated against seasonal influenza and pneumococcal infections increased in the COVID-19 pandemic, the number of patients vaccinated with these vaccines is still low. © 2021 by Turkish Society of Medical Oncology.","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69820279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Impact of the COVID-19 Pandemic on Follow-Up and Management of Cancer Patients COVID-19大流行对癌症患者随访和管理的影响

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/jos.2021-83957

M. Karakurt Eryılmaz, M. Karaağaç, M. Koçak, M. Korkmaz, Muzaffer Uğraklı, Engin Hendem, A. Demirkıran, M. Er, D. Çağlayan, M. Araz, H. Bozcuk, M. Artaç

{"title":"The Impact of the COVID-19 Pandemic on Follow-Up and Management of Cancer Patients","authors":"M. Karakurt Eryılmaz, M. Karaağaç, M. Koçak, M. Korkmaz, Muzaffer Uğraklı, Engin Hendem, A. Demirkıran, M. Er, D. Çağlayan, M. Araz, H. Bozcuk, M. Artaç","doi":"10.37047/jos.2021-83957","DOIUrl":"https://doi.org/10.37047/jos.2021-83957","url":null,"abstract":"ABS TRACT Objective: This study aimed to evaluate the impact of the coronavirus disease-2019 (COVID-19) pandemic on the follow-up and management of cancer patients. Material and Methods: A survey consisting of 15 questions asking whether there was a delay in follow-up or treatment of cancer during the COVID-19 pandemic was applied to the cancer patients who were admitted to our medical oncology out-patient clinic for follow-up or treatment. Results: A total of 209 cancer patients were included in this study. In 56 (26.8%) patients, there was a delay in the follow-up or treatment of cancer. The delay in cancer treatment occurred in 37 (66%) patients, and the delay in the follow-up of cancer occurred in 19 (34%) patients. The median delay in the follow-up and treatment of cancer was both 30 days (range 1-120) and (range 2-120), respectively. 12.5% of all patients who encountered delays in cancer follow-up or treatment had subsequent cancer-related complications. Also, the delay was significantly higher in quarantined patients and patients diagnosed with severe acute respiratory syndrome-coronavirus-2. In binary logistic regression analysis, living in rural areas and being quarantined due to the COVID-19 pandemic were deter-mined as independent predictors of the delay. Conclusion: The COVID-19 outbreak caused delays in the follow-up and treatment of cancer patients, and acute complications arose due to unavoidable disruptions. To prevent long-term negative consequences of delays in cancer fol-low-up and treatment, it is necessary to adapt the treatments judiciously without sacrificing patient safety and care.","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69820470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Distribution Data of Epidermal Growth Factor Receptor Mutations Detected by Next-Generation Sequencing Method in Non-Small Cell Lung Cancer 新一代测序法检测非小细胞肺癌中表皮生长因子受体突变的分布数据

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/jos.2021-84407

İ. Gökmen, E. Taştekin, A. Gökyer, Sezin Sayın, I. Çiçin

引用次数: 0

Anti-Yo Associated Paraneoplastic Cerebellar Degeneration in Ovarian Cancer: A Rare Case Report 卵巢癌中抗- yo相关的副肿瘤小脑变性:一个罕见的病例报告

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/JOS.2020-78768

Yusuf Ilhan, M. Korkmaz, E. Güzel, K. Mammadova, S. S. Göksu, A. Tatlı, H. Coşkun

引用次数: 0

Association Between Blood Type and Epidermal Growth Factor Receptor Mutation Positivity in Lung Adenocarcinoma Patients 肺腺癌患者血型与表皮生长因子受体突变阳性的关系

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/JOS.2020-79248

M. Gürbüz, E. Akkuş, Bilgin Karaalioğlu, E. Aktaş, E. B. Köksoy, Hilal Özakıncı, S. Hayme, Y. Urun, S. Sak, A. Demirkazık, G. Utkan

引用次数: 0

Same Disease, Different Approaches: A Report on Six Lymphoma Cases with Extranodal Marginal Zones in Rare Sites 同病不同治:罕见部位结外边缘区淋巴瘤6例报告

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/JOS.2020-79452

Metin Demir, D. Guven, S. Kılıçkap

引用次数: 1

Ixabepilone in Metastatic Breast Cancer: Real-World Experience 伊沙匹隆治疗转移性乳腺癌:真实世界的经验

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/jos.2021-81340

Ş. Gündüz, D. Erdem, D. Güven, S. Aksoy, M. Uysal, A. Kargi, A. Yıldız, I. Karaman, M. Özdoğan

引用次数: 0

Multiple Primary Synchronous Gastric, Esophageal, and Rectal Cancer and Isolated Esophageal Metastasis from Rectal Cancer: Case Report 胃癌、食管癌、直肠癌多发原发同步及孤立性食管转移:1例报告

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/jos.2020-80507

G. Sönmez, A. Aytekin, R. Erten, M. Aldemir, A. Sakin, R. Esen

{"title":"Multiple Primary Synchronous Gastric, Esophageal, and Rectal Cancer and Isolated Esophageal Metastasis from Rectal Cancer: Case Report","authors":"G. Sönmez, A. Aytekin, R. Erten, M. Aldemir, A. Sakin, R. Esen","doi":"10.37047/jos.2020-80507","DOIUrl":"https://doi.org/10.37047/jos.2020-80507","url":null,"abstract":"neoplasms identified simultaneously or within 6 months after the initial diagnosis in the same patient.1 However, synchronous tumors of the gastric and rectum carcinoma are not infrequent; particularly in the elderly male patient.2 The most commonly detected synchronous tumors in patients with gastric cancer are colorectal cancers, which are followed by lung, esophagus, and liver cancers.2 Rectal carcinoma commonly metastasizes to the liver, lungs, bone, brain, and lymph nodes.3 Esophageal metastasis of rectal carcinoma is an unusual occurrence owing to its rarity and challenges in diagnosis. Therefore, patients might be misdiagnosed sometimes and not be treated properly. Secondary carcinoma of the esophagus occurs as a result of the direct invasion, hematogenous, or lymphatic spread from the distant primary sites.4 Approximately 3.1-6.1% of patients who had died from any type of cancer in the autopsy series reported esophageal metastasis. Additionally, it has shown that the most common primary malignancies that metastasize to the esophagus are breast and lung cancers in the same autopsy series.3,5 Herein, we present the case of a 63-year-old man with synchronous gastric, rectal carcinoma, and in situ esophageal carcinoma who also had isolated esophageal metastasis from rectal carcinoma. J Oncol Sci. 2021;7(3):159-62","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69819835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparison of Clinicopathological Characteristics of BRCA1 and BRCA2 Carriers with Breast Cancer: The Role of Ki-67 Index BRCA1和BRCA2携带者乳腺癌临床病理特征的比较:Ki-67指数的作用

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/jos.2021-81821

Recep Ak, C. Karaçin, T. Bahşi, Ö. B. Öksüzoğlu

引用次数: 0

Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists 确定土耳其老年肿瘤的现状:一项医学肿瘤学家的调查

Journal of Oncological Sciences Pub Date : 2021-01-01 DOI: 10.37047/JOS.2020-80824

Baran Akagunduz, D. Guven, M. Atçı, I. Cil, C. Karaçin, Muhammet Ozer, S. Kılıçkap

{"title":"Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists","authors":"Baran Akagunduz, D. Guven, M. Atçı, I. Cil, C. Karaçin, Muhammet Ozer, S. Kılıçkap","doi":"10.37047/JOS.2020-80824","DOIUrl":"https://doi.org/10.37047/JOS.2020-80824","url":null,"abstract":"cer patients is 70 years and above.1 Recently, the rising life expectancy in the general population coupled with a disproportionate cancer burden among individuals aged 70 years and older have enthralled considerable interest in ensuring improved cancer treatment for the geriatric population.2 Significant limitation persists regarding optimal cancer treatment for older patients. Unique challenges are witnessed in the management of geriatric cancer patients. A thorough examination of the older person’s health status can aid in the assessment of risks and benefits of cancer treatment, affect the choice and intensity of treatment, and guide supportive care strategies.3 The central domains of geriatric assessment (GA) include physical and cognitive function assessment, comorbid medical problems, diet, medications, and psychological conditions.4 Despite the recommendations of the International Society of Geriatric Oncology (SIOG) and the National Comprehensive Cancer Network (NCCN), time restrictions mostly impede the systematic implementation of the application of geriatric assessment in oncology practice.5,6 To collect data without the time commitment and stress on patients and caregivers, cancer-specific geriatric evaluation tools have been designed.7 Nevertheless, the implementation of geriatric evaluation in daily medical oncology practice remains elusive.","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"7 1","pages":"25-30"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69819894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0